Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrec...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nichols KK, Holland E, Toyos MM, Peace JH, Majmudar P, Raychaudhuri A, Hamdani M, Roy M, Shojaei A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/a0522dfed8ed48989c87d173b448d181
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a0522dfed8ed48989c87d173b448d181
record_format	dspace
spelling	oai:doaj.org-article:a0522dfed8ed48989c87d173b448d1812021-12-02T03:03:59ZOcular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]1177-5483https://doaj.org/article/a0522dfed8ed48989c87d173b448d1812018-05-01T00:00:00Zhttps://www.dovepress.com/corrigendum-ocular-comfort-assessment-of-lifitegrast-ophthalmic-s-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrectly.Read the original article.Nichols KKHolland EToyos MMPeace JHMajmudar PRaychaudhuri AHamdani MRoy MShojaei ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 913-914 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Nichols KK Holland E Toyos MM Peace JH Majmudar P Raychaudhuri A Hamdani M Roy M Shojaei A Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
description	Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrectly.Read the original article.
format	article
author	Nichols KK Holland E Toyos MM Peace JH Majmudar P Raychaudhuri A Hamdani M Roy M Shojaei A
author_facet	Nichols KK Holland E Toyos MM Peace JH Majmudar P Raychaudhuri A Hamdani M Roy M Shojaei A
author_sort	Nichols KK
title	Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
title_short	Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
title_full	Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
title_fullStr	Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
title_full_unstemmed	Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
title_sort	ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in opus-3, a phase iii randomized controlled trial [corrigendum]
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/a0522dfed8ed48989c87d173b448d181
work_keys_str_mv	AT nicholskk ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT hollande ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT toyosmm ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT peacejh ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT majmudarp ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT raychaudhuria ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT hamdanim ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT roym ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum AT shojaeia ocularcomfortassessmentoflifitegrastophthalmicsolution50inopus3aphaseiiirandomizedcontrolledtrialcorrigendum
_version_	1718401999244886016

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

Ejemplares similares